Search
Quoin Pharmaceuticals Ltd
QNRXAdd to Watchlist
4.010USD
+0.020+0.50%
Close 10-21 16:00（ET）
8.05MMarket Cap
LossP/E TTM
Quoin Pharmaceuticals Ltd (QNRX) Stock Price Target & Forecast
Analyst Rating
Based on 7 analysts giving stock ratings to Quoin Pharmaceuticals Ltd in the past month.
Buy
1 Strong Buy
6 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
20.714USD+431.14%
QNRX Analyst Recommendation Trends
In the current month, QNRX has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. QNRX average Analyst price target in the last month is 20.714.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
1
0
0
0
0
0
0
0
6
5
4
4
3
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
5
4
4
3
2
2
2
QNRX Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
18
0
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
Biontech SE
BNTX
4
12
8
0
0
24
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
Cytokinetics Inc
CYTK
5
16
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Financial Forecasting
Based on analysts' estimates, QNRX EPS is projected to reach -1.608 in FY2026Q3, following reported EPS of -66.358 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-3.34
-1.93
-1.61
-1.61
-1.49
Actual
-60.64
-61.79
-66.36
--
--
Surprise
-1717.27%
-3107.00%
-4021.61%
--
--
FAQs
What is Quoin Pharmaceuticals Ltd's price target?
Analysts forecast that Quoin Pharmaceuticals Ltd's price target is USD 20.38, with the highest forecast at USD 35.00 and the lowest forecast at USD 12.00.
How have Quoin Pharmaceuticals LtdQNRX's recent earnings per share performed?
The market expectation was USD -66.36, while Quoin Pharmaceuticals LtdQNRX's earnings per share (EPS) for the previous quarter was USD -61.79. EPS for the next quarter is expected at USD -1.61.
What is the analyst rating for Quoin Pharmaceuticals Ltd?
Based on the ratings of Quoin Pharmaceuticals Ltd's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.